TOKYO, March 30 (Reuters) - Takeda Pharmaceutical Co., Japan’s largest drug maker, said on Friday it has acquired from 3M Co. the rights for a drug being developed as a treatment for human papillomavirus infection.
TOKYO, March 30 (Reuters) - Takeda Pharmaceutical Co., Japan’s largest drug maker, said on Friday it has acquired from 3M Co. the rights for a drug being developed as a treatment for human papillomavirus infection.
